KATHERINE FRANCO: Open Payments
NPI 1134636509 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 13 payments from 8 companies in 2025. Trend: 2023 $459 · 2024 $232 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: XIFAXAN, Kerendia, FARXIGA, AIRSUPRA, SYNTHROID, JARDIANCE, The Cologuard Plus Collection Kit, GARDASIL 9.
Industry payments across FL — which companies pay providers there.
